by Plataforma LAC | May 23, 2022 | About the fund, News
Source: theglobalfund.org Geneva – The Global Fund has signed a letter of intent with Pfizer for the procurement of up to 6 million treatment courses of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™, in 2022-2023....
by Plataforma LAC | May 23, 2022 | About the fund, News
Source: aidspan.org Among the several background papers for information provided to the 47th Board meeting held on 10-12 May 2022 was the annual update on Community, Rights and Gender. While members appreciated the progress that had been made, they also felt that the...
by Plataforma LAC | May 23, 2022 | About the response against AIDS, TB and Malaria, News
Source: Corresponsales Clave On Thursday, April 21, Corresponsales Clave, LAC Platform, LAC Vaccine Access, and the Platform for ACT-A Civil Society and Communities organized a webinar for Latin America and the Caribbean, focusing on the Access to COVID-19 Tools...
by Plataforma LAC | May 23, 2022 | About the fund, News
Source: theglobalfund.org GENEVA – The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria held its 47th Board meeting this week in Geneva. A few months ahead of the Global Fund’s Seventh Replenishment Conference to be hosted by the United...
by Plataforma LAC | Apr 28, 2022 | About the fund, News
Source: endmalaria.org World Malaria Day sees the global malaria community unite to make 2022 a pivotal year in the fight against the disease Geneva, 21 2022 – On World Malaria Day, 25 April, the global malaria community is uniting to celebrate global efforts...
